arrow
T

Tania Kümpfel

Ludwig-Maximilians-Universitat Munchen
H指数:62
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antibodies against MLC1 found in patients with NMOSD-like disease mediate astrocytopathy in rodent models

NMOSD样疾病患者中发现的抗MLC1抗体介导啮齿动物模型中的星形胶质细胞病变

2026-08-260
PRE
Hyperreflective Foci in the Inner Nuclear Layer: Proof-of-Concept for an Optical Coherence Tomography Derived Microglia-Related Marker in Multiple Sclerosis

内核层高反射焦点:多发性硬化中基于光学相干断层扫描的微胶质细胞相关标记的概念验证

2026-04-070
OAAI
[18F]Fluorodeprenyl-D2 PET as a Tool to Monitor Disease Activity in GAD65-Ab Autoimmune Encephalitis

[18F]氟代去甲丙咪嗪-D2 PET作为一种监测GAD65-Ab自身免疫性脑炎疾病活动的工具

2026-03-010
OAAI
Antigen specificity of clonally enriched CD8+ T cells in multiple sclerosis

多发性硬化中克隆富集的CD8 T细胞的抗原特异性

2026-02-050
OAAI
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab—A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS)

年龄,低免疫球蛋白G和M血清水平可预测利妥昔单抗治疗的AQP4-IgG NMOSD患者的感染-德国视神经脊髓炎研究组 (NEMOS) 的一项多中心队列研究

2026-02-040
OAAI
Cellular and humoral vaccination response under immunotherapies—German consensus on vaccination strategies in neurological autoimmune diseases

细胞和体液疫苗接种反应在免疫疗法下——德国关于神经自身免疫性疾病疫苗接种策略的共识

2025-12-120
OA
External validation of a multiple sclerosis treatment decision score using data from the ProVal-MS cohort study

利用ProVal-MS队列研究数据对一种多发性硬化治疗决策评分进行外部验证

2025-11-210
OA
Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis

多发性硬化症的遗传风险变异和与鞘内免疫球蛋白G合成相关的其他基因座

2025-11-010
PRE
Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study)

视神经脊髓炎谱系障碍(NMOSD)和MOG抗体介导的中枢神经系统脱髓鞘疾病(MOGAD)患者及其伴侣的二元应对:一项关于策略的社会学和心理学考察(CoMMOnsense研究)

2025-10-020
OAAI
SV2A-PET imaging uncovers cortical synapse loss in multiple sclerosis

SV2A-PET成像揭示了多发性硬化中的皮层突触丢失

2025-10-011
PRE
[18F]fluorodeprenyl-D2 PET can detect and monitor astrogliosis in anti-LGI1-IgG autoimmune encephalitis

[18F]fluorodeprenyl-D2 PET可以检测并监测抗LGI1-IgG自身免疫性脑炎中的星形胶质细胞增生

2025-09-260
OAAI
HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis

HLA-A∗03:01作为预测干扰素β治疗反应的遗传生物标志物在多发性硬化中的研究:一项回顾性队列分析

2025-07-310
PRE
Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study)

急性发作后恢复更差以及残疾累积更快,突显了晚期发作视神经脊髓炎谱系障碍(COPTER-LO研究)患者对改进治疗的未满足需求。

2025-04-110
PRE
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD

关于NMOSD和MOGAD免疫疗法的选择和有效性的真实世界多中心队列研究

2024-12-270
PRE
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks
2024-11-040
OAAI
Twin study identifies early immunological and metabolic dysregulation of CD8+ T cells in multiple sclerosis

双胞胎研究确定多发性硬化症中CD8 T细胞的早期免疫和代谢失调

2024-09-270
PRE
Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study)
2024-07-301
PRE